21
Calcium Antagonists Tatyana Voyno- Yasenetskaya [email protected] 312-996-9823

Calcium Antagonists Tatyana Voyno-Yasenetskaya [email protected] 312-996-9823

Embed Size (px)

Citation preview

Page 1: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Calcium Antagonists

Tatyana Voyno-Yasenetskaya

[email protected]

312-996-9823

Page 2: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

ATP ADP

Ca2+

Ca2+

Na+

Ca2+-ATPaseNa+ -driven Ca2+ antiport

2 mM

Ca2+

Ca2+

ATP ADP

Ca2+

MitochondriaCa2+-bindingproteins

Ca2+-ATPase

Ca2+-sequestering compartments

Regulation of Ca2+ extrusion

100 nM

Page 3: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

R

Gq

PLC

IP3DAG

Receptor-dependent Ca2+ entry

Regulation of Ca2+ entry

Voltage-dependent Ca2+ channel Polarized

DepolarizedClosed

Open-activeOpen-inactive

Page 4: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

1

2

SS

Subunit composition of L-type Ca2+ channel

• L-type (long-lasting)-excitation/contraction coupling of cardiac myocytes (nifedipine, verapamil, diltiazem)

• T-type (transient) - participate in pace making, highly expressed in sinusal cells (mibefradil)

• N-, P-type - expressed in neurons, are not affected by Ca2+ antagonists

Page 5: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

ACTIVATION

INACTIVATION

SELECTIVITY

VOLTAGE SENSOR

DILTIAZEMNIFEDIPINE VERAPAMIL

P

PP

P

P

P

STRUCTURE OF THE L-TYPE CHANNEL ALPHA SUBUNIT

E/C COUPLING

4

Page 6: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Calmodulin

Ca2+ channels blockers

Ca2+ channels

Ca2+ (intracellular)

Ca2+ - calmodulin complex

MLCK

Myosin light chain P

Myosin-actin interaction

Contraction

Control of smooth muscle contraction and the site of action of calcium

channel-blocking drugs

Page 7: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Calcium Antagonists

• Bind to specific sites on the alpha1 subunit of the L-type Ca2+ channel

• Reduce the probability of channel opening rather then calcium current flow through an open channel

• Tissue selectivity is one of the most beneficial properties of Ca2+ antagonists

• In general, skeletal muscle, bronchial, tracheal, and intestinal smooth muscle and neuronal tissue are relatively insensitive to Ca2+ antagonists

Page 8: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

SMOOTH MUSCLE

Relaxation due to Ca2+ decrease•Decrease in blood pressure

•Decrease in vascular resistance

CARDIAC MUSCLE

* Excitation/contraction* Impulse generation in sinoatrial node* Conduction in atrioventricalar node

Require Ca2+ influxDECREASE IN OXYGEN

REQUIREMENT

Page 9: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823
Page 10: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

VASCULAR SELECTIVITY

INCREASED CORONARY PERFUSION

IMPROVED OXYGEN SUPPLY

DECREASED PERIPHERAL RESISTANCE

CONTRACTION ENERGY SAVING

IMPROVED HEART PERFORMANCE

FLOWAFTERLOAD

BP

Page 11: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

myocardium vessels sino-atrial node

verapamildiltiazemnifedipinenimodipinefelodipinenisoldipineamlodipine

+++++++

+++++++++++++++++++

++-----

Degree of tissue selectivity of

calcium antagonist in clinical

use

Amlodipine is currently the most commonly prescribed calcium blocker for hypertension

Page 12: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Angina and Calcium Antagonists

• Angina is a chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by heart

• Classic angina is caused by atherosclerosis

• Angiospastic or variant angina is caused by vasospasm

Page 13: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Angina and Calcium Antagonists

• VASODILATIONCan be used in Prinzmetal’ anginaEffective at coronary vasospasmNot recommended in unstable angina or MI

• INCREASED OXYGEN SUPPLYMyocardial oxygen extraction is almost maximal

~75% of the available oxygen under no stress condition, thus there is no reserve to meet increased demand. The increased demand is me by increasing coronary blood flow

• DECREASE OXYGEN DEMANDThree major determinants of the myocardial oxygen

uptake are heart rate, blood pressure, and the contractile status of the myocardium

Page 14: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Angina and Calcium Antagonists

Calcium Antagonists

• Reduce blood pressure because of peripheral vasodilation

• Reduce heart rate, especially diltiazem and verapamil

• Decrease contractility thereby reducing the oxygen demand

Page 15: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Hypertension and Calcium Antagonists

• Mechanism of action is VASODILATION

• Nifedipine is used commonly because is 10 times more

selective to vascular smooth muscle cells than to myocardial

cells• Often used in patients with

contraindications to beta-antagonists

Page 16: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Arrhythmia and Calcium Antagonists

Arrhythmia results from• Abnormal pacemaker activity

• Abnormal impulse propagation

Aim of therapy• To reduce ectopic pacemaker

activity

• To modify impulse propagation

Page 17: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Arrhythmia and Calcium Antagonists

Supraventricular dysrhythmia(diltiazem,

verapamil)

• Mechanism of action is selectivity for pacemaker and nodal cells.

Blocks Ca2+-dependent conduction in AV node, thereby reducing atrioventricular conduction

• Restores synapse rhythm in 75% cases

Page 18: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Other Uses

• Migraine• Prevent development of atheromatous

lesions• Pulmonary artery hypertension

Page 19: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Side EffectsDiltiazem

• Edema• Headache

• Depresses sinoatrial nodal function because of high degree atrioventricular nodal block

Nifedipine• Dizziness is the result of acute vasodilation and rapid blood

pressure fall• Headaches is the result of vasodilation

• Ankle edema is caused by precapillary vasodilation

Verapamil• May increase digoxin level when used in combination

• Absolutely contraindicated in digoxin toxicity because will cause high grade AV block

• High rate of constipation up to 30%, presumably due to a specific interaction of verapamil with calcium channels in

smooth muscle cells of the gut• Depresses sinoatrial nodal function, may cause high degree

atrioventricular nodal block

Page 20: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

Contraindications

• Patients with low baseline blood pressure -may develop hypotension

• Patients with decreased left ventricular systolic function - may worsen the heart failure

•Arrythmias with antegrade conduction down a bypass tract, such as

syndrome Wolff-Parkinson-White

Page 21: Calcium Antagonists Tatyana Voyno-Yasenetskaya Tvy@uic.edu 312-996-9823

DRUG INTERACTION

DRUG AFFECTED MECHANISM PHARMACOKINETICEFFECTCT

POTENTIALCLINICALEFFECT

Digoxin Decreasedclearance

Increased serumdigoxin concentration

Digoxin toxicity

Carbmazepine Decreasedclearance

Increased serumcarbmazepineconcentration

Neurotoxicity(dizziness,headache, ataxia)

Antihistamines Decreasedclearance

Increased exposure toactive drug

Ventriculararrhythmia

HMG-CoAreductase inhibitors

Decreasedclearance

Increased exposure toactive drug

Myopathy

Immunosuppressivedrugs

Decreasedclearance

Increased exposure toactive drug

Nephrotoxicity

Beta-blockers Decreasedclearance

Increased exposure toactive drug

Bradycardia,asystole